Tonix Pharmaceuticals Appoints Ganesh Kamath As Head Of Market Access; Strengthens Leadership

Tonix Pharmaceuticals Holding Corp. has announced the appointment of Ganesh Kamath as its new Head of Market Access, effective September 29, 2025. The move strengthens Tonix’s leadership team as it continues expanding its commercial presence while advancing its pipeline of innovative therapies.

“Joining Tonix at this pivotal time presents an opportunity to help unlock the commercial value of Tonmya as we prepare to bring it to market for patients with fibromyalgia. I look forward to working with Tonix’s leadership team to drive operational execution, and position the company for long-term growth across the portfolio,” said Ganesh Kamath. 

Mr. Kamath brings extensive global experience in finance, business development, and market access. Most recently, he served as Vice President of FP&A, Business Development, and Sales Operations at CuriaGlobal, where he led key initiatives to enhance operational performance and strategic growth. Previously, he was Senior Vice President and Chief Financial Officer at Hutchmed International, where he developed pricing governance frameworks and drove market access strategies.

“Ganesh brings deep expertise in market access and a history of delivering results at leading global organizations, including Bayer HealthCare, Hutchmed International, and CuriaGlobal. As we prepare for the commercial launch of Tonmya™ and continue advancing our pipeline, his leadership in pricing, contracting, and payer engagement will help ensure patients have timely access to our therapies while driving operational momentum across the business,” said Thomas Englese, EVP Commercial of Tonix Pharmaceuticals. 

Earlier in his career, Mr. Kamath held senior leadership positions at Bayer HealthCare, where he managed strategic pricing, contracting, reimbursement, and gross-to-net management across a portfolio of more than 25 brands. He is a Chartered Accountant and earned his Bachelor of Science from the University of Calicut. His expertise is expected to play a critical role in shaping Tonix’s global market access and reimbursement strategies.